PGE2 is a crucial mediator of the proto-oncogenic actions of COX (28).Therefore, COX-2 inhibitor use lowers urine PGE2 levels, which lowers the incidence of colorectal cancers and adenomas (12, 13). This evidence concerns the gene PTGS2 and colorectal cancer.